| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 09/11/2009 | CA2716863A1 Sub-type selective amides of diazabicycloalkanes |
| 09/11/2009 | CA2716706A1 Compounds and compositions as tlr activity modulators |
| 09/10/2009 | US20090227794 Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1h-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
| 09/10/2009 | US20090227622 enzyme inhibitor; 2-{2-Fluoro-4-[7-(2-methyl-pyridin-4-yl)-imidazo[1,2-a]pyridin-3-yl]-phenyl}-N-(3-trifluoromethyl-phenyl)-acetamide; angiogenesis inhibitor; antitumor agent; treating hyperglycemia, psoriasis, rheumatoid arthritis, Kaposi's sarcoma, autoimmune diseases, inflammation, and eye disorders |
| 09/10/2009 | US20090227621 Naphthyridine derivatives having inhibitory activity against hiv integrase |
| 09/10/2009 | US20090227619 Harmine derivatives, intermediates used in their preparations, preparation processes and use therefo |
| 09/10/2009 | US20090227578 Azabenzimidazole Derivatives, Their Manufacture and Use as Anti-Cancer Agents |
| 09/10/2009 | US20090227571 Androgen Receptor Modulator Compounds and Methods |
| 09/10/2009 | US20090227565 Biphenyl Vasopressin Agonists |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/09/2009 | EP2098524A1 Process for preparing enantiomerically pure indolopyrinidines |
| 09/09/2009 | EP2098523A1 Novel compounds with affinity for amyloid |
| 09/09/2009 | EP2098522A1 Novel compound having affinity for amyloid |
| 09/09/2009 | EP2098513A1 Tricyclic compound and pharmaceutical use thereof |
| 09/09/2009 | EP2098508A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/09/2009 | EP2097414A1 Pyrrolo [2, 3-b]pyridine derivatives as kinase modulators |
| 09/09/2009 | EP2097412A2 Fungicidal n-heteroaryl-condensed pyridine derivatives and fungicidal compositions |
| 09/09/2009 | EP2097411A1 3 -amino-imidazo [1,2 -a]pyridine derivatives having an sglt1 and sglt2 inhibiting action, for treating type 1 and type 2 diabetes |
| 09/09/2009 | EP2097376A2 Spiro-piperidine derivatives |
| 09/09/2009 | EP2096923A2 Heteroaryl amide derivatives |
| 09/09/2009 | EP1957488B1 3-amino-2-arylpropyl azaindoles and uses thereof |
| 09/09/2009 | EP1902050B1 Oxazolidinone derivatives and use thereof as antibiotics |
| 09/09/2009 | EP1784404A4 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof |
| 09/09/2009 | EP1553923B1 Camptothecin-carboxylate formulations |
| 09/09/2009 | EP1539753B1 Pyrazolo(3,4-b)pyridine compounds, and their use as phosphodiesterase inhibitors |
| 09/09/2009 | CN101528746A Spirocyclic azetidinone derivatives for the treatment of disorders of lipid metabolism, pain, diabetes and other disorders |
| 09/09/2009 | CN101528745A Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes |
| 09/09/2009 | CN101528744A Compositions and methods for modulating C-KIT and PDGFR receptors |
| 09/09/2009 | CN101528743A Fused heterocyclic derivatives and methods of use |
| 09/09/2009 | CN101528742A Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them |
| 09/09/2009 | CN101528741A Polycyclic viral inhibitors |
| 09/09/2009 | CN101525335A Full-bridge linked triphenylamine compound and application thereof in electroluminescent device |
| 09/09/2009 | CN100537568C 6-substituted pyridoindolone derivatives, production method and therapeutic use thereof |
| 09/09/2009 | CN100537538C Nove intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 09/09/2009 | CN100537527C Aryl and biaryl compounds having MCH modulatory activity |
| 09/09/2009 | CN100536839C Urea derivatives as integrin alpha 4 antagonists |
| 09/08/2009 | US7585976 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 09/08/2009 | US7585975 A group is bonded to at least one of the carbons at the 5, 6, 7 or 8 position of the bicyclic ring, and the ring is substituted by up to three independent R3 groups. The invention also includes methods of using these compounds as type I receptor tyrosine kinase inhibitors and hyperproliferation diseases |
| 09/08/2009 | US7585974 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/08/2009 | US7585876 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 09/08/2009 | US7585874 2-(5-methyl-3-phenyl-isoxazol-4-yl)-imidazo[1,2-a]pyridine; 8-methyl-2-(5-methyl-3-phenyl-isoxazol-4-yl)-imidazo[1,2-a]pyridine; high affinity and selectivity for gamma-aminobutyric acid (GABA) A alpha 5 receptor binding sites; Alzheimer's disease |
| 09/08/2009 | US7585873 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 09/08/2009 | US7585869 novel bicyclic derivatives that are useful in the treatment of abnormal cell growth, such as cancer; tyrosine kinase inhibitors |
| 09/08/2009 | CA2316388C Tetrahydrobenzindole derivative |
| 09/03/2009 | WO2009108827A1 Fused tricyclic pyrazolo[1, 5-a]pyrimidines, methods for preparation and uses thereof |
| 09/03/2009 | WO2009108670A1 Protein kinase inhibitors and use thereof |
| 09/03/2009 | WO2009108332A1 INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1 |
| 09/03/2009 | WO2009107850A2 Fused heterocyclic derivative and use thereof |
| 09/03/2009 | WO2009107767A1 Novel bicyclic pyrimidine derivative having antagonistic activity on h4 receptor |
| 09/03/2009 | WO2009106982A1 Indazole derivatives |
| 09/03/2009 | WO2009106752A2 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106751A2 Derivatives of n-heterocyclic-6-heterocyclic-imidazo[l,2- a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106750A2 Derivatives of 6-heterocyclic-imidazo[l,2-a]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106749A2 Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106748A2 Derivatives of n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106745A2 Method for enantio-selective preparation of sulphoxides |
| 09/03/2009 | WO2009106534A1 Novel heterocyclic carboxamides as m1 agonists |
| 09/03/2009 | WO2009106307A1 Substituted 4-aminocyclohexane derivatives for the treatment of pain |
| 09/03/2009 | WO2009081246A3 Bicyclic diamines as nicotinic receptor agonists |
| 09/03/2009 | WO2009062676A3 Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| 09/03/2009 | WO2009056990A3 Paliperidone polymorphs |
| 09/03/2009 | WO2009047613A3 An improved process for the preparation of tadalafil intermediate |
| 09/03/2009 | US20090221828 Process for Preparing 1-Halo-2,7-Naphthyridinyl Derivatives |
| 09/03/2009 | US20090221699 Fab I Inhibitors |
| 09/03/2009 | US20090221632 Bicyclo-Pyrazoles and Pharmaceutical Compositions Comprising Them |
| 09/03/2009 | US20090221631 Imidazopyridinones |
| 09/03/2009 | US20090221627 Fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use |
| 09/03/2009 | US20090221623 Indole Alkaloid Derivatives Having Opioid Receptor Agonistic Effect, and Therapeutic Compositions and Methods Relating to Same |
| 09/03/2009 | US20090221611 Fused Triazole Tachykinin Receptor Antagonists |
| 09/03/2009 | US20090221600 Pyrido-pyridimidine derivatives useful as antiinflammatory agents |
| 09/03/2009 | US20090221595 Crystalline form of sitagliptin |
| 09/03/2009 | US20090221573 Use of Activators of Soluble Guanylate Cyclase for Promoting Wound Healing |
| 09/03/2009 | US20090221571 Hiv integrase inhibitors |
| 09/03/2009 | US20090221562 Novel opioid antagonists |
| 09/03/2009 | US20090221556 Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods |
| 09/03/2009 | US20090221551 Substituted fused[1,2] imidazo[4,5c] ring compounds and methods |
| 09/03/2009 | US20090218940 Phenanthroline compound and organic light emitting device using same |
| 09/03/2009 | DE102008011817A1 New ferromagnetic 2,9-bis-(2-hydroxymethyl-2-propylpentyl)anthra(2,1, 9-def;6,5,10-d'e'f')diisoquinolin-1,3,8,10-tetra-on-radical anion-tetrabutylammonium salt in the form of e.g. powder, useful e.g. to construct transformers and coils |
| 09/03/2009 | CA2716773A1 Fused heterocyclic derivative and use thereof |
| 09/03/2009 | CA2716755A1 Protein kinase modulators |
| 09/03/2009 | CA2716613A1 Substituted 4-aminocyclohexane derivatives for the treatment of pain |
| 09/03/2009 | CA2716128A1 Inhibitors of 11.beta.-hydroxysteroid dehydrogenase type 1 |
| 09/03/2009 | CA2714573A1 Indazole derivatives |
| 09/03/2009 | CA2714111A1 Tetrahydro-1h-pyrrolo fused pyridones |
| 09/03/2009 | CA2712990A1 Protein kinase inhibitors and use thereof |
| 09/03/2009 | CA2710962A1 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereef and therapeutic application thereof |
| 09/03/2009 | CA2710947A1 Derivatives of 6-heterocyclic-imidazo[1,2-a]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | CA2710943A1 Derivatives of n-phenyl-imidazo[1,2-.alpha.]pyridine-2-carboxamides, preon thereof and therapeutic application thereof |
| 09/03/2009 | CA2710860A1 Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | CA2710794A1 Derivatives of n-heterocyclic-6-heterocyclic-imidazo[l,2-.alpha.]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/02/2009 | EP2094704A2 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 09/02/2009 | EP2094703A1 Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes |
| 09/02/2009 | EP2094702A2 Viral inhibitors |
| 09/02/2009 | EP2094701A2 Compounds and methods for kinase modulation, and indications therefor |
| 09/02/2009 | EP2094700A2 Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile |
| 09/02/2009 | EP2094699A2 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7 |
| 09/02/2009 | EP2094698A1 Substituted 6-phenyl-pyrido [2,3-d]pyrimidin-7-one derivatives as kinase inhibitors and methods for using the same |
| 09/02/2009 | EP2094697A1 5-sulfanylmethyl-pyrazolo [1,5-a]pyrimidin-7-ol derivatives as cxcr2 antagonists |
| 09/02/2009 | EP2094696A1 5-sulfanylmethyl-[1,2,4] triazol[1, 5-a] pyrimidin-7-ol derivatives as cxcr2 antagonists |